Laboratory research material

Research Use OnlyNot for human or veterinary use

SEMAX

$35.00

In animal studies, Semax changes the amount or activity of signaling proteins such as BDNF and TrkB that cells use to adapt and communicate.

SKU: N/A Category:

Research focus

  • Neurotrophin signaling
  • Neuronal stress responses
  • Gene-response models
Laboratory Research Disclaimer

All chemical compounds available on this portal are engineered strictly for in-vitro laboratory evaluation and scientific research purposes only. These products are definitively not intended for human therapeutic, clinical, diagnostic, or veterinary applications.

Order reviewConfirm item and optionSecure checkoutProtected payment flowCOA accessReview available documentation

Documentation status

No public lot-specific report is posted for this product or selected variation. Do not infer identity, purity, sterility, endotoxin status, potency, or suitability from another product's report.

What Is SEMAX?

Semax is a synthetic heptapeptide built from the ACTH(4-7) region and extended with Pro-Gly-Pro, giving the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is studied as a neuropeptide research material without the corticosteroid-producing activity associated with full-length ACTH.

Overview

Laboratories use Semax in preclinical systems to examine neurotrophin signaling, including BDNF and TrkB, as well as gene-expression changes, peptide-degrading enzymes, and neurotransmitter-related pathways. In plain language, researchers use it to see how a short peptide changes the molecular signals nerve cells use to adapt and communicate under baseline or stressed conditions.

Researchers are interested in Semax because it offers a compact way to probe the proteins and genes nerve cells use when adapting to an experimental challenge.

History

Semax was developed through work at the Institute of Molecular Genetics of the Russian Academy of Sciences and collaborating institutions. Researchers modified an ACTH-derived sequence with a Pro-Gly-Pro extension to improve stability while separating it from the endocrine activity of the parent hormone. Much of the published literature comes from Russian research groups and preclinical models.

Research Findings

  • Preclinical studies have reported changes in BDNF expression, TrkB signaling, and related neurotrophin markers.
  • Gene-expression experiments have identified responses involving neuronal signaling, stress pathways, and synaptic-plasticity-related targets.
  • Laboratory work has examined interactions with peptide-degrading enzymes and changes in monoamine-related markers.
  • Independent replication is limited compared with more established neurobiology tools, and findings depend on model, timing, and assay design.

Documentation

Available analytical reports apply only to the exact product, strength, and lot identified on each report. A report for one strength or lot must not be assumed to cover another. Contact Fit Club Elite before ordering when a project requires lot-specific documentation.

Use Restrictions

For Research Use Only. Not for human or veterinary use. Not a food, drug, cosmetic, dietary supplement, or household product. Fit Club Elite does not provide medical, dosing, mixing, reconstitution, administration, or end-use guidance. Purchasers are responsible for lawful handling, storage, and use in an appropriate research setting.

Size

10mg

Research context

Review sources and documents

Research area
Non-clinical neurobiology and transcriptomic models
Last updated
September 30, 2026

Use these links to review published research. A source is not a protocol, recommendation, or promise that a result will apply in a different research model.

Starting references reviewed

For laboratory research only. Not for human or veterinary use. We do not provide medical, dosing, mixing, or administration instructions.

Shopping Cart